NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis
NetworkNewsAudio released an audio press release featuring Quantum BioPharma, highlighting the development of its Lucid-MS drug candidate for multiple sclerosis. The content describes Lucid-MS as a first-in-class therapy targeting the myelin sheath, designed to prevent, stop, or reverse degradation based on preclinical models. The release also notes Quantum's retained 19.84% ownership in Unbuzzd Wellness Inc.
Key figures
- Ms market size 2024
- $27.4 billion
- Unbuzzd royalty cap
- $250 million
- Ms market forecast 2030
- $38.62 billion
- Unbuzzd ownership percent
- 19.84%
- Unbuzzd royalty rate pre cap
- 7%
- Unbuzzd royalty rate post cap
- 3%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.